Efficacy of telcagepant in subgroups: pooled analysis of data from phase 3 studies

被引：0
|
作者：
Ho, T. W. [1 ]
Connor, K. M. [1 ]
Ho, A. P. [1 ]
Kost, J. T. [1 ]
Fan, X. [1 ]
Dodick, D. W. [2 ]
Silberstein, S. D. [3 ]
Lines, C. R. [1 ]
Assaid, C. [1 ]
机构：
[1] Merck & Co Inc, N Wales, PA USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
200
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] Efficacy of Telcagepant in Subgroups: Pooled Analysis of Data from Phase 3 Studies
    Ho, Tony W.
    Connor, Kathryn M.
    Ho, Andrew P.
    Kost, James T.
    Fan, Xiaoyin
    Dodick, David W.
    Silberstein, Stephen D.
    Lines, Christopher R.
    Assaid, Christopher
    NEUROLOGY, 2010, 74 (09) : A396 - A397
  • [2] Efficacy of telcagepant in subgroups: pooled analysis of data from phase 3 studies
    Ho, T. W.
    Connor, K. M.
    Ho, A. P.
    Kost, J. T.
    Fan, X.
    Dodick, D. W.
    Silberstein, S. D.
    Lines, C. R.
    Assaid, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 245 - 245
  • [3] Efficacy of Telcagepant in Subgroups: Pooled Analysis of Data from Phase 3 Studies
    Ho, T. W.
    Connor, K. M.
    Ho, A. P.
    Kost, J. T.
    Fan, X.
    Dodick, D. W.
    Silberstein, S. D.
    Lines, C. R.
    Assaid, C.
    HEADACHE, 2010, 50 : S16 - S16
  • [4] Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies
    Seneschal, Julien
    Wolkerstorfer, Albert
    Desai, Seemal R.
    Grimes, Pearl
    Ezzedine, Khaled
    Pandya, Amit G.
    Kornacki, Deanna
    Wei, Shaoceng
    Passeron, Thierry
    Rosmarin, David
    DERMATOLOGY AND THERAPY, 2025, : 1227 - 1238
  • [5] Safety and Efficacy of Fremanezumab in Different Racial and Ethnic Subgroups of Patients with Migraine: A Pooled Analysis of Phase 3 Studies
    Charleston, Larry
    Cohen, Joshua M.
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Lengil, Tamar
    Ojwang, Beryl
    Kim, Byung-Kun
    ANNALS OF NEUROLOGY, 2022, 92 : S42 - S43
  • [6] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Mease, Philip J.
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela S.
    Helliwell, Philip
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [7] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Philip J. Mease
    Ana-Maria Orbai
    Oliver FitzGerald
    Mohamed Bedaiwi
    Rajiv Dona L. Fleishaker
    Pamela Mundayat
    Philip S. Young
    Arthritis Research & Therapy, 25
  • [8] EFFICACY OF AVATROMBOPAG COMPARED WITH PLACEBO ACROSS VARIOUS MEAN BASELINE PLATELET COUNT SUBGROUPS-POOLED DATA FROM 2 PHASE 3 STUDIES
    Saab, Sammy
    Alkhouri, Naim
    Allen, Lee F.
    Aggarwal, Kavita
    Vredenburg, Michael
    Tian, Wei
    GASTROENTEROLOGY, 2018, 154 (06) : S1249 - S1249
  • [9] Efficacy of avatrombopag compared with placebo across various mean baseline platelet count subgroups-pooled data from 2 Phase 3 studies
    Sammy, S.
    Alkhouri, N.
    Allen, L. F.
    Aggarwal, K.
    Vredenburg, M.
    Tian, W.
    Terrault, N.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S751 - S751
  • [10] Clinical equivalence of evolocumab among patient subgroups in PROFICIO: a pooled analysis of 3146 patients from phase 3 studies
    Stroes, E.
    Robinson, J.
    Raal, F.
    Dufour, R.
    Sullivan, D.
    Blagden, M.
    Kassahun, H.
    Yang, J.
    Wasserman, S.
    Koren, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 307 - 308
12345